Article Per Year (5 Year)
p-Index From 2021 - 2026
0
P-Index
This Author published in this journals
All Journal Cermin Dunia Kedokteran Cermin Dunia Kedokteran
Christina Permata Shalim
RSUD Wangaya, Denpasar, Bali, Indonesia
Health Professions Medicine & Pharmacology Public Health

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
Diagnosis dan Tatalaksana Irritable Bowel Syndrome Christina Permata Shalim
Cermin Dunia Kedokteran Vol 46, No 12 (2019): Kardiovaskular
Publisher : PT. Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v46i12.396

Abstract

Irritable Bowel Syndrome (IBS) merupakan penyakit dengan prevalensi global mencapai 11%. Gejala IBS yang tidak spesifik dan serupa penyakit saluran pencernaan lain menyulitkan diagnosis sehingga banyak pemeriksaan penunjang yang sebenarnya tidak perlu. Diagnosis IBS ditegakkan berdasarkan kriteria Rome IV. Patofisiologi IBS belum sepenuhnya dipahami dan terapi lebih bersifat simtomatik sesuai subtipe IBS dan gejala yang mendominasi, terdiri dari terapi non farmakologi dan farmakologi. Beberapa terapi farmakologi baru mulai dikembangkan.Irritable Bowel Syndrome (IBS) affects around 11% global population. Non specific symptoms of IBS and similarities with other gastrointestinal disorder cause difficulties in diagnosis and excessive diagnostic tests. Diagnosis is according to Rome IV criteria. The pathophysiology of IBS is not yet fully understood and most of the existing therapies are symptomatic according to subtype and the predominant symptoms, consisting of non-pharmacological and pharmacological therapies. Some new pharmacological therapies are being developed.
Diagnosis dan Tatalaksana Irritable Bowel Syndrome Christina Permata Shalim
Cermin Dunia Kedokteran Vol 46 No 12 (2019): Kardiovakular
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v46i12.393

Abstract

Irritable Bowel Syndrome (IBS) merupakan penyakit dengan prevalensi global mencapai 11%. Gejala IBS yang tidak spesifik dan serupa penyakit saluran pencernaan lain menyulitkan diagnosis sehingga banyak pemeriksaan penunjang yang sebenarnya tidak perlu dilakukan. Diagnosis IBS ditegakkan berdasarkan kriteria Rome IV. Patofisiologi IBS belum sepenuhnya dipahami dan terapi lebih bersifat simptomatik sesuai subtipe IBS dan gejala yang mendominasi, terdiri dari terapi non-farmakologi dan farmakologi. Beberapa terapi farmakologi baru mulai dikembangkan. Irritable Bowel Syndrome (IBS) affects around 11% global population. Non-specific symptoms of IBS and similarities with other gastrointestinal disorder cause difficulties in diagnosis and excessive diagnostic tests. Diagnosis is according to Rome IV criteria. The pathophysiology of IBS is not yet fully understood and most of the existing therapies are symptomatic according to subtype and the predominant symptoms, consisting of non-pharmacological and pharmacological therapies. Some new pharmacological therapies are being developed.
Diagnosis dan Tatalaksana Irritable Bowel Syndrome Christina Permata Shalim
Cermin Dunia Kedokteran Vol 46 No 12 (2019): Kardiovakular
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v46i12.393

Abstract

Irritable Bowel Syndrome (IBS) merupakan penyakit dengan prevalensi global mencapai 11%. Gejala IBS yang tidak spesifik dan serupa penyakit saluran pencernaan lain menyulitkan diagnosis sehingga banyak pemeriksaan penunjang yang sebenarnya tidak perlu dilakukan. Diagnosis IBS ditegakkan berdasarkan kriteria Rome IV. Patofisiologi IBS belum sepenuhnya dipahami dan terapi lebih bersifat simptomatik sesuai subtipe IBS dan gejala yang mendominasi, terdiri dari terapi non-farmakologi dan farmakologi. Beberapa terapi farmakologi baru mulai dikembangkan. Irritable Bowel Syndrome (IBS) affects around 11% global population. Non-specific symptoms of IBS and similarities with other gastrointestinal disorder cause difficulties in diagnosis and excessive diagnostic tests. Diagnosis is according to Rome IV criteria. The pathophysiology of IBS is not yet fully understood and most of the existing therapies are symptomatic according to subtype and the predominant symptoms, consisting of non-pharmacological and pharmacological therapies. Some new pharmacological therapies are being developed.
Co-Authors